Operating in India: Tackling Entry Challenges and Country-Specific Legal and Cultural Dynamics to Strengthen and Monitor Compliance
Foley Partner David Simon spoke at ACI’s 20th Annual FCPA & Anti-Corruption for the Life Sciences Industry Conference in New York on May 8, 2025. He participated in a panel discussion focused on India, titled “Tackling Entry Challenges and Country-Specific Legal and Cultural Dynamics to Strengthen and Monitor Compliance.”
Doing business in India presents significant opportunities for life sciences companies but comes with unique regulatory, legal, and cultural challenges. The panel discussed current enforcement trends (both U.S. and India) and explored key strategies for successful market entry in India, strengthening compliance frameworks amidst country-specific anti-corruption laws, and best practices for monitoring operations while maintaining business integrity.